British Columbia Investment Management Corp Hutchmed (China) LTD Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	BUY	$23.7 - $39.27 $116,130 - $192,423	4,900 Added 16.01%	35,500 $1.39 Million
Q2 2020 Aug 12, 2020	BUY	$17.65 - $28.05 $58,244 - $92,565	3,300 Added 12.09%	30,600 $844,000
Q1 2020 May 13, 2020	BUY	$15.19 - $29.51 $15,190 - $29,510	1,000 Added 3.8%	27,300 $487,000
Q3 2019 Nov 14, 2019	BUY	$17.84 - $22.69 $26,760 - $34,035	1,500 Added 6.05%	26,300 $469,000
Q1 2019 May 08, 2019	BUY	$21.27 - $30.58 $2,127 - $3,058	100 Added 0.4%	24,800 $758,000
Q4 2018 Feb 13, 2019	BUY	$23.09 - $37.69 $570,323 - $930,943	24,700 New	24,700 $570,000

Others Institutions Holding HCM

# of Institutions

Shares Held

6.88M

Call Options Held

6.2K

Put Options Held

1.1K

Schroder Investment Management Group London, X0

2.92M
Shares

$41.8 Million
0.06% of portfolio
Allianz Asset Management Gmb H Munich, 2M

1.32M
Shares

$18.9 Million
0.04% of portfolio
State Street Corp Boston, MA

350K
Shares

$5 Million
0.0% of portfolio
Aia Group LTD Hong Kong, K3

315K
Shares

$4.51 Million
0.17% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

310K
Shares

$4.43 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.47B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account